Ten things you must know when producing synthetic therapeutic peptides

Peptide therapeutic agents are enjoying increasing success but they are challenging to produce and, not least, to purify. Purity requirements are, in fact, approaching those for small molecules. Synthesis generates a crude mixture containing failed sequences and chemical variants. 

We asked an expert

We asked a seasoned industry expert who currently works in this area and who has more than 35 years experience in chromatography, including the resin business, drug discovery, scaling-up and GMP production of biological pharmaceuticals:

• How do you best plan and carry out a purification process for a synthetic therapeutic peptide?
• What are the most critical and fundamental factors to focus on and where do most processes, or people, go wrong?

It's all summarized in ten points and nine pages

The answers are summarized in the nine-page guide that you can download for free at the bottom of this page.

Is this your first time setting up a protocol and you want to avoid the most ridiculous mistakes at least? 

Do you know it all already? Or are there a few things you've forgotten about?

Get it right from the start, do a sanity check on your standard thinking or get a nice training list to hand out to your colleagues... whatever your interest, we hope you'll find something useful here.

Download it now!

All product and company names marked with ™ are trademarks or registered trademarks of Bio-Works or of the respective trademark holders. Use by Bio-Works of trademarks of other holders does not imply any affiliation with or endorsement by them.